+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Grifols, S.A. - logo

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

Critical Care Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Critical Care Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026 - Product Thumbnail Image

Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026

  • Report
  • August 2021
  • 159 Pages
  • Global
From
Intravenous Immunoglobulin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Intravenous Immunoglobulin Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Thymectomy, Cholinesterase Inhibitors, Rapid Immunotherapies), By End-use (Hospitals, Clinics), By Region and Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Thymectomy, Cholinesterase Inhibitors, Rapid Immunotherapies), By End-use (Hospitals, Clinics), By Region and Segment Forecasts, 2023 - 2030

  • Report
  • October 2023
  • 120 Pages
  • Global
From
Pharmaceutical RTU Market - Global Forecast to 2030 - Product Thumbnail Image

Pharmaceutical RTU Market - Global Forecast to 2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Report 2026 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Antinuclear Antibody Test Market 2025-2029 - Product Thumbnail Image

Antinuclear Antibody Test Market 2025-2029

  • Report
  • May 2025
  • 207 Pages
  • Global
From
ESR Analyzers Market - Global Strategic Business Report - Product Thumbnail Image

ESR Analyzers Market - Global Strategic Business Report

  • Report
  • April 2026
  • 383 Pages
  • Global
From
Blood Viscometers Market - Global Strategic Business Report - Product Thumbnail Image

Blood Viscometers Market - Global Strategic Business Report

  • Report
  • April 2026
  • 275 Pages
  • Global
From
ELISA Analyzers - Global Strategic Business Report - Product Thumbnail Image

ELISA Analyzers - Global Strategic Business Report

  • Report
  • April 2026
  • 477 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Gel Documentation Systems - Global Strategic Business Report - Product Thumbnail Image

Gel Documentation Systems - Global Strategic Business Report

  • Report
  • April 2026
  • 244 Pages
  • Global
From
Laboratory Bottle-Top Dispensers - Global Strategic Business Report - Product Thumbnail Image

Laboratory Bottle-Top Dispensers - Global Strategic Business Report

  • Report
  • April 2026
  • 224 Pages
  • Global
From
Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026 - Product Thumbnail Image

Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026

  • Report
  • November 2021
  • 175 Pages
  • Global
From
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • United States
2024 Australia Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Australia Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Australia
From
2024 Malaysia Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Malaysia Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Malaysia
From
2024 Slovenia Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Slovenia Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Slovenia
From
2024 Guatemala Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Guatemala Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Guatemala
From
2024 Dominican Republic Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays - Product Thumbnail Image

2024 Dominican Republic Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • Report
  • May 2024
  • Dominican Republic, Dominica Dominican Republic, Dominica
From
Loading Indicator